Medisun Precision Medicine Ltd. (MPME) Financial Statements (2024 and earlier)

Company Profile

Business Address TRUST COMPANY COMPLEX
MAJURO, MH96960
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

6/30/2017
MRQ
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 1,336,9371,811,871555,506818,070
Cash and cash equivalents 1,336,9371,811,871555,506818,070
Other undisclosed current assets  199,906  
Total current assets: 1,336,9372,011,777555,506818,070
Noncurrent Assets
Property, plant and equipment 123,445166,119  
Intangible assets, net (including goodwill) 1,025,393  94,251
Intangible assets, net (excluding goodwill) 1,025,393  94,251
Other undisclosed noncurrent assets 260,0862,067,694944,005 
Total noncurrent assets: 1,408,9242,233,813944,00594,251
TOTAL ASSETS: 2,745,8614,245,5901,499,511912,321
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 39,784180,782266,026209,679
Other undisclosed accounts payable and accrued liabilities 39,784180,782266,026209,679
Debt 498,820   
Due to related parties  149,000105,00030,000
Other undisclosed current liabilities  (149,000)(105,000)(30,000)
Total current liabilities: 538,604180,782266,026209,679
Noncurrent Liabilities
Other undisclosed noncurrent liabilities  383,980353,059350,000
Total noncurrent liabilities:  383,980353,059350,000
Total liabilities: 538,604564,762619,085559,679
Equity
Equity, attributable to parent, including: 2,207,2573,680,828880,425352,642
Common stock 920751579316
Additional paid in capital 14,172,48612,639,9786,425,1511,161,960
Accumulated deficit (11,966,149)(10,091,902)(5,547,305)(809,634)
Other undisclosed equity, attributable to parent  1,132,0012,000 
Other undisclosed equity   1 
Total equity: 2,207,2573,680,828880,426352,642
TOTAL LIABILITIES AND EQUITY: 2,745,8614,245,5901,499,511912,321

Income Statement (P&L) (USD)

6/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Operating expenses (1,660,321)(2,637,627)(4,699,766)(759,730)
Operating loss: (1,660,321)(2,637,627)(4,699,766)(759,730)
Nonoperating income
(Debt Instrument, Convertible, Beneficial Conversion Feature)
   20,000 
Interest and debt expense  144,505  
Loss from continuing operations before income taxes: (1,660,321)(2,493,122)(4,679,766)(759,730)
Income tax expense   (1,610,808) 
Loss from continuing operations: (1,660,321)(2,493,122)(6,290,574)(759,730)
Loss before gain (loss) on sale of properties: (1,660,321)(2,493,122)(6,290,574)(759,730)
Net loss: (1,660,321)(2,493,122)(6,290,574)(759,730)
Other undisclosed net income (loss) attributable to parent (213,927)(71,475)1,552,904(10,979)
Net loss available to common stockholders, diluted: (1,874,248)(2,564,597)(4,737,670)(770,709)

Comprehensive Income (USD)

6/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss: (1,660,321)(2,493,122)(6,290,574)(759,730)
Comprehensive loss, net of tax, attributable to parent: (1,660,321)(2,493,122)(6,290,574)(759,730)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: